The Government's Continued Assault On Drug Pricing Could Hurt The Health Of Americans
These renewed attacks on biopharma continue to erode its reputation, thereby handicapping the industry’s ability to develop new cures and to confront any new pandemic. That will negatively impact us all.
Source: forbes.com